← Leaderboards
Zachary Yochum
University Of Pittsburgh At Pittsburgh
$147,893
Attributed
$147,893
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.5K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$147,893 · 1
By mechanism
F30$147,893 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Andrew F. Stewart$27,613,128
- Adolfo Garcia-Ocana$10,799,833
- Reza Zarnegar$10,558,814
- Youhua Liu$11,880,962
- George K Michalopoulos$12,892,897
Others in their field
Other Emerging Leaders on “Apoptosis”
- Deanna A Kulpa · Emory University$8,444,989
- Yamuna Krishnan · University Of Chicago$5,740,000
- Peter J Leary · University Of Washington$5,643,326
- Tanya Christineh Petrossian · Endomet Biosciences, Inc$4,570,776
- Yanbo Fan · University Of Cincinnati$4,484,838
- William Raymond Lagor · Baylor College Of Medicine$4,366,036
Research focus
ApoptosisAkt2 GeneBcl2l11 GeneBiologicalApoptoticBiologyCancer Cell LineCancer EtiologyCancer PatientCancer TherapyBiological MarkersChemotherapyClassificationCrizotinibDown-RegulationEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpithelialErlotinibFoxo3a GeneGene RepressionGenesCessation Of LifeGenetic
Grant awards (3)
Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma$49,325
F30 · FY2019 · CA · contact PI
Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma$49,524
F30 · FY2018 · CA · contact PI
Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma$49,044
F30 · FY2017 · CA · contact PI